Commutee

Senate reauthorizes FDA to collect fees from drugmakers

August 3, 2017 by  
Filed under News

(Reuters) – The U.S. Senate on Thursday passed a bill allowing the Food and Drug Administration to continue collecting fees from drug companies to review new product applications.


Source: Reuters Business News

Comments are closed.